Clinofibrate
98%
- Product Code: 50633
CAS:
30299-08-2
| Molecular Weight: | 468.59 g./mol | Molecular Formula: | C₂₈H₃₆O₆ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00865769 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
Clinofibrate is primarily used as a lipid-lowering agent to manage hyperlipidemia, a condition characterized by elevated levels of lipids in the blood. It works by reducing the synthesis of cholesterol and triglycerides in the liver, thereby helping to lower overall lipid levels in the bloodstream. This makes it effective in preventing complications associated with high cholesterol, such as atherosclerosis, heart attacks, and strokes. It is often prescribed as part of a comprehensive treatment plan that includes dietary changes, exercise, and other medications to improve cardiovascular health. Additionally, it may be used in patients with specific lipid disorders to achieve better control of their lipid profiles.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Almost white powder to crystal |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | ฿2,880.00 |
+
-
|
| 0.200 | 10-20 days | ฿8,450.00 |
+
-
|
Clinofibrate
Clinofibrate is primarily used as a lipid-lowering agent to manage hyperlipidemia, a condition characterized by elevated levels of lipids in the blood. It works by reducing the synthesis of cholesterol and triglycerides in the liver, thereby helping to lower overall lipid levels in the bloodstream. This makes it effective in preventing complications associated with high cholesterol, such as atherosclerosis, heart attacks, and strokes. It is often prescribed as part of a comprehensive treatment plan that includes dietary changes, exercise, and other medications to improve cardiovascular health. Additionally, it may be used in patients with specific lipid disorders to achieve better control of their lipid profiles.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :